Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

2,119 questions · 2,206 findings · 117 reviews · Common Mental Disorders

No studies found 387 · 17.5%GRADE not reported 111 · 5%Very low 635 · 28.8%Low 568 · 25.7%Moderate 449 · 20.4%High 56 · 2.5%

Intervention not reported

Total sleep time Participant reports. Scale from: 300 to 840; more minutes equalled better outcome; CFB and double‐blind average values included · Patients with insomnia
1 finding from 1 review
  • Eszopiclone for insomnia 2018 · Cochrane Headline outcomes only
    no estimate extracted
    9 studies · 2935 participants
    Moderate

Intervention not reported

Next‐day alertness Participant reports. Scale from: 0 to 10 points; higher scores equalled better outcome; CFB and double‐blind average values included · Patients with insomnia
1 finding from 1 review

Intervention not reported

Serious adverse events (as defined in the primary study) Participant reports. Serious adverse events observed during double‐blind treatment period · Patients with insomnia
1 finding from 1 review
  • Eszopiclone for insomnia 2018 · Cochrane Headline outcomes only
    no estimate extracted
    12 studies · 4289 participants
    Moderate

Tricyclic antidepressants vs placebo

Adverse events (at 4, 6 or 12 weeks) · adults with insomnia

Tricyclic antidepressants showed no clear difference in adverse events (at 4, 6 or 12 weeks) compared with placebo (low certainty).

1 finding from 1 review

Client feedback vs no client feedback

Treatment acceptability: dropouts from treatment · children and adolescents, 11 to 18 years old, with mental health problems

It is very uncertain whether client feedback changes treatment acceptability: dropouts from treatment compared with no client feedback (very low certainty).

1 finding from 1 review